<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS207040</article-id><article-id pub-id-type="doi">10.1101/2025.06.25.661481</article-id><article-id pub-id-type="archive">PPR1043308</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mutations within the predicted fragment-binding region of FAM83G/SACK1G abolish its interaction with the Ser/Thr kinase CK1α</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Utgés</surname><given-names>Javier S.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xuan</surname><given-names>Diane Lee Zhi</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chatelier</surname><given-names>Brune Le</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Glennie</surname><given-names>Lorraine</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Macartney</surname><given-names>Thomas J.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Nicola T.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Barton</surname><given-names>Geoffrey J.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sapkota</surname><given-names>Gopal P.</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Computational Biology, School of Life Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03h2bxq36</institution-id><institution>University of Dundee</institution></institution-wrap>, <addr-line>Dow Street</addr-line>, <city>Dundee</city>, <postal-code>DD1 5EH</postal-code>, <city>Scotland</city>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03x94j517</institution-id><institution>Medical Research Council (MRC)</institution></institution-wrap> Phosphorylation &amp; Ubiquitylation Unit, School of Life Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03h2bxq36</institution-id><institution>University of Dundee</institution></institution-wrap>, <addr-line>Dow Street</addr-line>, <city>Dundee</city>, <postal-code>DD1 5EH</postal-code>, <city>Scotland</city>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1"><label>*</label>Correspondence: <email>g.sapkota@dundee.ac.uk</email>, <email>gjbarton@dundee.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>07</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>27</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">SACK1G (aka FAM83G, PAWS1) plays a central role in activating canonical WNT signalling via interaction with the Ser/Thr kinase CK1α. This loss of CK1α binding and WNT signalling underlies the pathogenesis of Palmoplantar Keratoderma (PPK) caused by several reported mutations in the <italic>SACK1G</italic> gene. We modelled the scaffold anchor of CK1 (SACK1) domain of SACK1G and used fragment-bound structures of the SACK1B (FAM83B) dimer to guide our analysis. This allowed us to computationally predict several key residues near the fragment-binding site in SACK1G that may be important for its function. We mutated these residues, introduced them into <italic>SACK1G</italic><sup>-/-</sup> DLD-1 colorectal cancer cells and investigated their ability to bind endogenous CK1α. We uncovered two SACK1G mutations, namely Y204A and I206A, that abolish interaction with CK1α similarly to the PPK pathogenic mutant A34E. Consistent with this loss of SACK1G-CK1α interaction, the molecular glue degrader of CK1α, DEG-77, fails to co-degrade the Y204A and I206A mutants while it still co-degrades native SACK1G. Our findings demonstrate the utility of our computational methods to uncover functional residues on proteins based on fragment-binding sites.</p></abstract><kwd-group><kwd>FAM83G</kwd><kwd>CK1α</kwd><kwd>FAM83B</kwd><kwd>SACK1</kwd><kwd>fragment screening</kwd><kwd>3D structure prediction</kwd><kwd>evolutionary divergence</kwd><kwd>conservation</kwd><kwd>missense variation</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The eight members (A-H) of the FAM83 family of proteins are characterised by the presence of the conserved <underline>S</underline>caffold <underline>A</underline>nchor of <underline>CK1</underline> domain (SACK1; formerly known as the Domain of Unknown Function DUF1669) but are otherwise different in sequence composition and length <sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>. The CK1 family of Ser/Thr protein kinases control a myriad of cellular processes, including cell cycle progression, circadian rhythms, WNT signalling and Sonic Hedgehog signalling <sup><xref ref-type="bibr" rid="R3">3</xref></sup>. Contrary to the dogma that CK1 isoforms are constitutively active kinases, their activity, subcellular localisation, and stability in cells is tightly regulated to allow phosphorylation of specific substrates and effectuate distinct biological outcomes, although how this is achieved is poorly understood <sup><xref ref-type="bibr" rid="R3">3</xref></sup>. In a series of recent discoveries, we identified the eight members of the FAM83/SACK1 family of proteins (hereafter referred to as SACK1 domain-containing proteins A-H, or SACK1A-H) as master regulators of CK1 isoforms <sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R9">9</xref></sup>. The conserved SACK1 domain of SACK1A-H proteins mediates their interaction with CK1 isoforms and dictates the subcellular distribution – and potentially substrates – of the interacting CK1 isoforms <sup><xref ref-type="bibr" rid="R2">2</xref></sup>. The precise molecular and biological roles of most SACK1 proteins are poorly defined. Among the best characterised functionally, the SACK1F-CK1α and SACK1G-CK1α interactions are known to drive the activation of canonical WNT signalling <sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>, while SACK1D-CK1α interaction at the mitotic spindle has been reported to ensure proper spindle orientation and timely and error-free progression through cell division cycle <sup><xref ref-type="bibr" rid="R10">10</xref></sup>.</p><p id="P3">Four different missense mutations, resulting in A34E, R52P, F58I and R265P substitutions, within the SACK1 domain of SACK1G have been reported to cause Palmoplantar Keratoderma (PPK), which is characterised by thickening of the skin on the palms and soles of the feet and abnormal hair growth, in both humans <sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup> and dogs <sup><xref ref-type="bibr" rid="R13">13</xref></sup>. These mutations are reported to abolish SACK1G-CK1α binding <sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup> and attenuate canonical WNT signalling <sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup>, highlighting the importance of CK1α binding for SACK1G function. Interestingly, a spontaneous deletion of a large part of the <italic>SACK1G</italic> gene from mice was reported to cause ‘<italic>wooly</italic>’ hair phenotype <sup><xref ref-type="bibr" rid="R14">14</xref></sup>. The functional convergence between SACK1G and CK1α is also highlighted by the similar PPK phenotypes evident in human patients displaying a loss in <italic>SACK1G</italic> expression <sup><xref ref-type="bibr" rid="R12">12</xref></sup> and transgenic mice targeted for ablation of CK1α expression from keratinocytes <sup><xref ref-type="bibr" rid="R15">15</xref></sup>.</p><p id="P4">The crystal structures of the SACK1 domains of FAM83A/SACK1A (PDB: 4URJ <sup><xref ref-type="bibr" rid="R16">16</xref></sup>) and FAM83B/SACK1B (PDB: 5LZK <sup><xref ref-type="bibr" rid="R17">17</xref></sup>) have been solved. The structures reveal a unique dimer with PLD1-like fold <sup><xref ref-type="bibr" rid="R18">18</xref></sup>. However, the prototypic catalytic “HKD” triad of PLD1 is not conserved in SACK1 proteins and no PLD activity for any of the SACK1 proteins has been reported. A structure-based fragment screening undertaken using the SACK1 domain of FAM83B/SACK1B has reported ten unique fragments bound to the SACK1 domain across eleven structures (PDB: 5QHI <sup><xref ref-type="bibr" rid="R19">19</xref></sup>, 5QHJ <sup><xref ref-type="bibr" rid="R20">20</xref></sup>, 5QHK <sup><xref ref-type="bibr" rid="R21">21</xref></sup>, 5QHL <sup><xref ref-type="bibr" rid="R22">22</xref></sup>, 5QHM <sup><xref ref-type="bibr" rid="R23">23</xref></sup>, 5QHN <sup><xref ref-type="bibr" rid="R24">24</xref></sup>, 5QHO <sup><xref ref-type="bibr" rid="R25">25</xref></sup>, 5QHP <sup><xref ref-type="bibr" rid="R26">26</xref></sup>, 5QHQ <sup><xref ref-type="bibr" rid="R27">27</xref></sup>, 5QHR <sup><xref ref-type="bibr" rid="R28">28</xref></sup> and 5QHS <sup><xref ref-type="bibr" rid="R29">29</xref></sup>). No structures of SACK1 domains from other SACK1 proteins have been reported nor are there reports of any known binding fragments or ligands. In this work, AlphaFold Multimer version 3 <sup><xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R32">32</xref></sup> was employed to generate 3D structure models of a SACK1G dimer. Using a combination of solvent accessibility, evolutionary divergence and enrichment in human population variation <sup><xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R36">36</xref></sup>, residues within a conserved binding site between SACK1B and SACK1G were ranked by their likelihood of function and prioritised for experimental validation.</p></sec><sec id="S2" sec-type="methods"><title>Methods</title><sec id="S3"><title>Computational Methods</title><sec id="S4"><title>Structure prediction</title><p id="P5">Protein three-dimensional (3D) structure models were generated using the Colabfold version 1.5.2 implementation <sup><xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R38">38</xref></sup> of AlphaFold Multimer (AFM) v3 <sup><xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R32">32</xref></sup>. Additionally, secondary structure predictions were obtained from the JPred 4 web server <sup><xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R42">42</xref></sup>. Protein sequences were obtained from UniProt <sup><xref ref-type="bibr" rid="R43">43</xref></sup> and domain annotations extracted from InterPro <sup><xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R45">45</xref></sup>. Models were obtained for dimers of the scaffolding anchor of CK1 (SACK1) domain (PF07894) – previously known as DUF1669 – of human SACK1B (Q5T0W9) and SACK1G (A6ND36). Sequence constructs included residues 1-286 and 1-315 for SACK1B and SACK1G, respectively, to ensure the full SACK1 domain was modelled. Models were visualised with ChimeraX <sup><xref ref-type="bibr" rid="R46">46</xref>–<xref ref-type="bibr" rid="R48">48</xref></sup>. Model quality was assessed at the interface level with the interface predicted template modelling (ipTM) score as well as the new interaction prediction score from aligned errors (ipSAE) <sup><xref ref-type="bibr" rid="R49">49</xref></sup> with <italic>dist</italic> and <italic>PAE</italic> thresholds of 15 Å. Predicted local distance difference test (pLDDT) and predicted aligned error (PAE) were utilised to measure model quality at the residue level.</p></sec><sec id="S5"><title>Fragment screening analysis</title><p id="P6">Eleven structures from a fragment screening experiment on the SACK1 (DUF1669) domain dimer of human SACK1B (Q5T0W9) were extracted from the PDBe <sup><xref ref-type="bibr" rid="R50">50</xref></sup>. Twenty-four ligand molecules, ten of which were unique, binding to the SACK1B dimer across the eleven structures, were grouped into six distinct ligand binding sites by the method of Utgés <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref></sup>. Binding sites and their residues were characterised by evolutionary divergence across homologues and human population missense variation constraint. jackHMMER <sup><xref ref-type="bibr" rid="R53">53</xref></sup> was employed to build a multiple sequence alignment for FAM83B and evolutionary divergence was quantified with the normalised Shenkin <sup><xref ref-type="bibr" rid="R54">54</xref></sup> divergence score, <italic>N<sub>Shenkin</sub></italic> <sup><xref ref-type="bibr" rid="R34">34</xref></sup>. Residue-level constraint within the human population was measured with a missense enrichment score (MES) <sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup> and variants from gnomAD <sup><xref ref-type="bibr" rid="R56">56</xref></sup>.</p><p id="P7"><italic>N<sub>Shenkin</sub></italic> is a divergence score ranging from 0 to 100. Positions that are conserved across homologues present lower divergence scores, <italic>N<sub>Shenkin</sub></italic> &lt; 25, while divergent positions present higher scores, <italic>N<sub>Shenkin</sub></italic> &gt; 75. MES is calculated as the natural logarithm of an odds ratio (OR) and expresses the likelihood of observing missense variants in an alignment column, or residue position, relative to the rest of the alignment (or protein). Positions enriched in missense variation present MES &gt; 0. Positions that are depleted in missense variation, i.e., are constrained within human, present MES &lt; 0. Neutral positions that are neither enriched nor depleted present MES = 0. Refer to our previous work <sup><xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R36">36</xref></sup> for more details on how these scores are calculated and interpreted.</p></sec></sec><sec id="S6"><title>Biological Methods</title><sec id="S7" sec-type="materials"><title>Materials</title><p id="P8">Anti-CK1α (SA527), anti- SACK1G (S685C), and anti-SACK1F (SA103) antibodies and Protein-G Sepharose beads coupled to anti-GFP nanobody were generated by the MRC PPU Reagents and Services. Anti-GAPDH antibody (Cat #2118) and goat anti-Rabbit IgG (H+L)-HRP (#7074) were from Cell Signaling Technology. Rabbit anti-sheep IgG (H+L)-HRP (#31480), Gibco DMEM and Fetal Bovine Serum (FBS) were obtained from Thermo Fisher Scientific. All plasmids employed in this study were generated by MRC PPU Reagents and Services at University of Dundee, with detailed information accessible at <ext-link ext-link-type="uri" xlink:href="https://mrcppureagents.dundee.ac.uk">https://mrcppureagents.dundee.ac.uk</ext-link>. DEG-77 was a kind gift from Christina Woo (Harvard).</p></sec><sec id="S8"><title>Cell culture</title><p id="P9">Human embryonic kidney cells 293FT, wild type DLD-1 colorectal cancer cells and <italic>SACK1G</italic> <sup>-/-</sup> DLD-1 cells <sup><xref ref-type="bibr" rid="R8">8</xref></sup> were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% FBS, 2 mM L-glutamine and 1% streptomycin/penicillin, maintained at 37°C in 5% CO<sub>2</sub> in humidified incubators. Indicated concentrations of DEG-77 were diluted in DMSO and added to cells, mixed by swirling and returned to the incubators for the indicated length of time prior to lysis. For production of retroviral vectors, the following were cloned into pBabeD-puromycin plasmids: WT SACK1G-GFP (DU20988), SACK1G<sup>A34E</sup>-GFP (DU29572) SACK1G<sup>V175A</sup>-GFP (DU71867), SACK1G<sup>I206A</sup>-GFP (DU71868), SACK1G<sup>Q301A</sup>-GFP (DU71869), SACK1G<sup>F260A</sup>-GFP (DU71874), SACK1G<sup>Y204A</sup>-GFP (DU71875), and SACK1G<sup>R235A</sup>-GFP (DU71885). All constructs were sequence-verified by the DNA Sequencing Service, University of Dundee (<ext-link ext-link-type="uri" xlink:href="https://dnaseq.co.uk/">http://www.dnaseq.co.uk</ext-link>). All constructs are available to request from the MRC-PPU Reagents and Services webpage (<ext-link ext-link-type="uri" xlink:href="https://mrcppureagents.dundee.ac.uk/">http://mrcppureagents.dundee.ac.uk</ext-link>) and the unique identifier (DU numbers) provide direct links to the cloning strategies and sequence details.</p></sec><sec id="S9"><title>Retroviral generation of stable cell lines</title><p id="P10"><italic>SACK1G</italic><sup>-/-</sup> DLD-1 cells stably expressing the different SACK1G-GFP mutants were generated via retroviral transduction by following established biological safety guidelines. Briefly, the pBabeD-puromycin vectors encoding the specific mutants (6 μg), pCMV5-gag/pol (3.2 μg) and pCMV5-VSV-G plasmids (2.8 μg) (Clontech) were co-transfected into ~60-70% confluent HEK-293FT cells in a 10-cm diameter dish using PEI reagent as previously described <sup><xref ref-type="bibr" rid="R57">57</xref>–<xref ref-type="bibr" rid="R59">59</xref></sup>. The medium was replaced with fresh medium after 16 h and the medium containing the retroviral particles was collected 48 h post-transfection, filtered through a 0.45 mm filter, and added to target <italic>SACK1G</italic> <sup>-/-</sup> DLD-1 cells along with 10 μg/ml polybrene (Sigma-Aldrich). 48 h later, successfully transduced cells were selected in fresh medium containing 2 μg/ml puromycin (Sigma-Aldrich) for a further 48 h.</p></sec><sec id="S10"><title>Cell Lysis</title><p id="P11">The cells were washed twice with ice-cold PBS and scraped on ice in lysis buffer (LB: 50 mM Tris-HCl (pH 7.5), 270 mM sucrose, 150 mM sodium chloride, 1 mM EDTA (pH 8.0), 1 mM EGTA (pH 8.0), 1 mM sodium orthovanadate, 10 mM sodium β-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1% (v/v) NP-40) supplemented with 1x cOmplete™ protease inhibitor cocktail (Roche) and 1 mM DTT. Cell lysates were transferred to Eppendorf tubes and vortexed briefly. The cell suspension was incubated for 15 min on ice to ensure complete lysis. The lysates were centrifuged at 17000 x g for 20 min at 4°C to remove cell debris, and cleared extracts were carefully transferred to new Eppendorf tubes. Protein concentration was measured using the Bradford assay and extracts were processed for SDS-PAGE &amp; immunoblotting or immunoprecipitation (IP).</p></sec><sec id="S11"><title>Immunoprecipitation</title><p id="P12">40 μL of 50% (v/v) slurry of anti-GFP-nanobody coupled Sepharose beads were added to cleared cell extracts (1 mg total protein) and IPs performed for 4 hours at 4°C on a rotating wheel. Pre-IP input samples and post-IP flowthrough (FT) extracts were collected to evaluate the IP efficiency and verify complete immune depletion of the target protein from the FT extracts. Following IP, the anti-GFP-nanobody coupled Sepharose beads were washed with 500 μL NP-40 lysis buffer thrice before IPs were resuspended in 50 μL of 1 x LDS sample buffer containing 1 mM DTT. The input and FT extracts were also reconstituted in 1 x LDS sample buffer containing 1 mM DTT and all samples were then denatured by boiling at 95 °C for 10 min prior to SDS-PAGE and immunoblotting.</p></sec><sec id="S12"><title>SDS-PAGE and Immunoblotting</title><p id="P13">Reduced and denatured cell extracts containing equal amounts of protein (20 μg) and anti-GFP IP samples (50% of total) were resolved by SDS-PAGE and samples transferred to pre-equilibrated polyvinylidene fluoride (PVDF) membranes. Membranes were blocked in 5% (w/v) non-fat milk in TBS-T (20 mM Tris, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature. Primary antibody diluted in 5% milk TBS-T was then incubated with the membranes overnight at 4°C on a shaking platform. Membranes were then washed 3x10 min in TBS-T with constant shaking and subsequently incubated with appropriate HRP-conjugated secondary antibodies (diluted in 5% milk/TBS-T), for 1 h at room temperature. Membranes were then washed 3x10 min in TBS-T and signal detection was performed by using chemiluminescence (Promega) on the ChemiDoc imaging system (Bio-Rad).</p></sec></sec></sec><sec id="S13" sec-type="results"><title>Results</title><sec id="S14"><title>SACK1B fragment screening analysis</title><p id="P14">Twenty-four fragments across eleven SACK1B structures were grouped into six different ligand binding sites (BS0 - BS5) using the method of Utgés <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R35">35</xref></sup> (<xref ref-type="fig" rid="F1">Figure 1 A</xref>). Binding sites 2, 3 and 5 present a Cluster 1 (C1) relative solvent accessibility label. Ligand sites in this cluster tend to be buried, conserved and depleted in missense variation in human. Moreover, C1 is strongly enriched in known functional sites <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. This suggests BS2, BS3 and BS5 might be functionally relevant. These three sites also present low sequence divergence across homologues and few missense variants (MES &lt; 0) across human paralogues (<xref ref-type="fig" rid="F1">Figure 1 B</xref>). This supports further their potential functional role. BS2 is at the predicted pseudo-PLD catalytic cleft, although whether it binds putative substrate phospholipids is yet to be determined <sup><xref ref-type="bibr" rid="R1">1</xref></sup> (<xref ref-type="fig" rid="F1">Figure 1 C</xref>). BS3 is at the interface between the two SACK1B dimer copies (<xref ref-type="fig" rid="F1">Figure 1 D</xref>) and BS5 is a buried pocket on the surface where twelve ligands bind (<xref ref-type="fig" rid="F1">Figure 1 E</xref>). Previous work demonstrated how D262A <sup><xref ref-type="bibr" rid="R2">2</xref></sup> and F296A <sup><xref ref-type="bibr" rid="R4">4</xref></sup> mutations in the same binding site in SACK1G disrupt binding to CK1α. Accordingly, BS5 was explored in more detail. The ten ligands grouped together in BS5 are adjacent to the two ligands in BS1 and for simplicity both sites were combined. This site of interest is formed by thirteen residues (<xref ref-type="fig" rid="F1">Figure 1 F</xref>). <xref ref-type="fig" rid="F1">Figure 1 G</xref> displays the relation between the missense enrichment score (MES) on the Y axis and the normalised Shenkin divergence score (<italic>N<sub>Shenkin</sub></italic>) on the X axis. Positions that are conserved (<italic>N<sub>Shenkin</sub></italic> &lt; 50) and missense-depleted (MES &lt; 0) are located on the bottom-left quadrant and are the most likely to have a role in the protein’s function since they are constrained both across members of the family and within the human population. Using these two measures of evolutionary constraint, the thirteen residues were ranked by the likelihood of influencing FAM83B function by disturbing CK1α binding (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Residues were stratified in three classes by their divergence and missense-enrichment scores: high likelihood (V149, F273, L233, L179 and D235), medium likelihood (Y277, Y177, D270 and C236) and low likelihood (A151, R274, R206, R208).</p><sec id="S15"><title>SACK1G dimer modelling</title><p id="P15">There are no experimentally determined structures for human protein SACK1G. Accordingly, a structural model for the SACK1G SACK1 domain dimer was obtained with AlphaFold Multimer (AFM) (<xref ref-type="fig" rid="F2">Figure 2</xref>) and structurally compared to the monomer model available in AlphaFold DB (AFDB). Both models presented very high confidence (pLDDT &gt; 90) for most of the domain except for a loop at positions 74-128 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1 A-B</xref>). This agrees with disorder prediction from MobiDB <sup><xref ref-type="bibr" rid="R60">60</xref></sup>. This loop, as well as a confidently predicted <italic>3-helix region</italic> towards the N-terminus at residues 29-73, are the locations where the two models differ. The model quality in this <italic>3-helix region</italic>, as well as its position relative to the structured core of the domain improve when modelling SACK1G as a dimer, indicated by higher pLDDT and lower PAE (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>). These helical regions were also predicted in the same location by JPred, lending confidence in their structure. Focusing on the well-structured region of the SACK1 domain (129-315), the models are structurally very similar with RMSD = 0.51 Å (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1 C-D</xref>). This structural similarity remains when comparing to the AFDB model of SACK1B and an experimental structure 5QHN <sup><xref ref-type="bibr" rid="R24">24</xref></sup> with RMSD = 0.65 Å (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1 E-F</xref>). This structural similarity suggests that a ligand binding site homologous to the one identified with the fragment screen of SACK1B might exist in SACK1G.</p><p id="P16">Both the AFM and AFDB models of SACK1G, as well as AFDB model of SACK1B, contain an extra region of structural coverage compared to experimentally resolved structures of SACK1B, e.g., 5QHN. This region includes residues 29-73 in SACK1G which fold into three α-helices (α1, α2 and α3) and is accordingly referred to as <italic>3-helix region</italic> (<xref ref-type="fig" rid="F3">Figure 3 A</xref>). Previous studies identified missense variants SACK1G<sup>A34E 11</sup> and SACK1G<sup>R52P 13</sup> as pathogenic leading to the development of palmoplantar keratoderma (PPK) in humans and dogs, respectively. Both variants fall within this 3-helix region suggesting this region is relevant for SACK1G function. A34 is located on α1 and forms a network of hydrophobic interactions with several residues on α2 including F46, V49, L50, I55 and F58. A change to a larger negatively charged residue like glutamate would very likely alter this network of contacts disrupting the helix packing. R52 does not interact with many residues within the region but could play a role in binding to CK1α as suggested by Glennie <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R9">9</xref></sup>.</p><p id="P17">Additionally, our SACK1G model included a confidently-predicted loop (pLDDT &gt; 70; PAE &lt; 5 Å) that is not present in the homologous SACK1B structures determined by X-ray crystallography. This loop is found at residues 128-145 and it seems to be covering or blocking the homologous SACK1G fragment binding site of interest defined from SACK1B (<xref ref-type="fig" rid="F3">Figure 3 B</xref>). If this site is indeed functionally relevant, as suggested by our analysis of solvent accessibility, evolutionary divergence and enrichment in variation, it could be that this loop has a protective role and blocks the site to ensure SACK1G function. This loop might be able to undergo a conformational change and move out of the pocket leaving the site accessible for ligand binding and allosteric modulation.</p></sec><sec id="S16"><title>SACK1G binding site analysis</title><p id="P18">A binding pocket of interest was defined on SACK1G thanks to the structural similarity between the experimentally determined structures of SACK1B and the AlphaFold Multimer model of the SACK1G dimer (<xref ref-type="fig" rid="F4">Figure 4 A</xref>). <xref ref-type="fig" rid="F4">Figure 4 B</xref> illustrates the evolutionary divergence and enrichment in human missense variation of the thirteen residues forming this site in the same way as it was done for the same pocket in SACK1B (<xref ref-type="fig" rid="F1">Figure 1 G</xref>). Residues were ranked based on likelihood of function using these two scores and stratified in three categories again: high, medium and low likelihood. Those residues presenting lower divergence and higher variant depletion were on the top of the list as they were constrained both across members of the family and within human. Six residues out of the thirteen forming the pocket were selected for alanine scanning and subsequent experimental functional assay. These were: V175, Y204, I206, R235, F260 and Q301. This residue selection, in conjunction with D262 and F296 – which are already known to abolish CK1α binding if mutated to alanine <sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup> – includes positions across the different conservation and variation classes defined in <xref ref-type="fig" rid="F4">Figure 4B</xref> and offers good structural coverage of the pocket.</p></sec><sec id="S17"><title>Impact of SACK1G mutants on SACK1G-CK1α binding</title><p id="P19">SACK1G associates with the Ser/Thr protein kinase CK1α and this association is critical in mediating WNT signalling activation. All four reported PPK pathogenic mutants of SACK1G (A34E, R52P, F58I and R265P) abolish their association with CK1α. Therefore, we sought to decipher how the six chosen mutations, namely V175A, Y204A, I206A, R235A, F260A and Q301A, within the SACK1 domain of SACK1G affect the SACK1G-CK1α interaction in cells. We stably restored the expression of wild type SACK1G, the PPK pathogenic SACK1G<sup>A34E</sup> mutant or each of the six chosen FAM83G mutants (SACK1G<sup>V175A</sup>, SACK1G<sup>I206A</sup>, SACK1G<sup>Q301A</sup>, SACK1G<sup>F260A</sup>, SACK1G<sup>Y204A</sup> and SACK1G<sup>R235A</sup>) all with a C-terminal GFP tag in <italic>SACK1G</italic><sup>-/-</sup> DLD-1 colorectal cells <sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup> (<xref ref-type="fig" rid="F5">Figure 5A</xref>). As expected, anti-GFP IPs from cells expressing wild type SACK1G co-precipitated endogenous CK1α but not from those expressing SACK1G<sup>A34E 5</sup> (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Anti-GFP IPs from cells expressing SACK1G<sup>V175A</sup>, SACK1G<sup>Q301A</sup>, SACK1G<sup>F260A</sup> and SACK1G<sup>R235A</sup> also co-precipitated endogenous CK1α (<xref ref-type="fig" rid="F5">Figure 5B</xref>), indicating that these mutations by themselves do not appear to interfere with the SACK1G-CK1α interaction. Excitingly, however, anti-GFP IPs from cells expressing SACK1G<sup>I206A</sup> and SACK1G<sup>Y204A</sup> did not co-precipitate endogenous CK1α (<xref ref-type="fig" rid="F5">Figure 5B</xref>).</p></sec></sec><sec id="S18"><title>Targeted degradation of CK1α co-deplete wild type SACK1G but not SACK1G<sup>I206A</sup> and SACK1G<sup>Y204A</sup> mutants</title><p id="P20">Previously, we reported that lenalidomide degrades the SACK1F-CK1α complex by recruiting CK1α to the CRBN-CUL4A E3 ligase complex for ubiquitin-mediated proteasomal degradation <sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Recently, two derivatives of lenalidomide, DEG-77 <sup><xref ref-type="bibr" rid="R61">61</xref></sup> and SJ3149 <sup><xref ref-type="bibr" rid="R62">62</xref></sup>, were shown to be potent degraders of CK1α acting via the CRBN-CUL4A E3 ligase complex. Using DEG-77 and SJ3149, we were able to demonstrate a robust co-depletion of the SACK1G-CK1α, as well as the SACK1F-CK1α complex <sup><xref ref-type="bibr" rid="R63">63</xref></sup>. We postulated that SACK1G<sup>I206A</sup> and SACK1G<sup>Y204A</sup> mutants would be resistant to degradation by DEG-77 as they no longer interact with CK1α. First, we optimised DEG-77 treatment conditions for co-depletion of SACK1G-CK1α complex in DLD-1 cells. Treatment of DLD-1 cells with increasing doses of DEG-77 for 24 h led to a dose-dependent depletion in levels of CK1α, SACK1G and SACK1F compared to DMSO treatment, with maximal depletion observed at concentrations above 100 nM (<xref ref-type="fig" rid="F6">Figure 6A</xref>). When cells were treated with 100 nM DEG-77 over a course of 24 h, co-depletion of CK1α, SACK1G and SACK1F was observed after 3 h, with maximal depletion observed at 24 h (<xref ref-type="fig" rid="F6">Figure 6A-B</xref>). Next, <italic>SACK1G</italic><sup>-/-</sup> DLD-1 cells stably expressing WT SACK1G-GFP, SACK1G<sup>A34E</sup>-GFP, SACK1G<sup>I206A</sup>-GFP and SACK1G<sup>Y204A</sup>-GFP were treated with 100 nM DEG-77 for 24 h (<xref ref-type="fig" rid="F6">Figure 6C</xref>). In cells expressing WT SACK1G-GFP, compared to DMSO control, DEG-77 robustly depleted both CK1α and SACK1G-GFP. In contrast, in cells expressing SACK1G<sup>A34E</sup>-GFP, SACK1G<sup>I206A</sup>-GFP and SACK1G<sup>Y204A</sup>-GFP, while CK1α was robustly degraded, no co-depletion of SACK1G<sup>A34E</sup>-GFP, SACK1G<sup>I206A</sup>-GFP and SACK1G<sup>Y204A</sup>-GFP was observed (<xref ref-type="fig" rid="F6">Figure 6C</xref>), confirming that these mutants abolish their interaction with CK1α. Further analysis through multiple sequence alignment (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>) revealed that Y204 is conserved across all SACK1 members, except for SACK1A, which interestingly exhibits the weakest binding affinity to CK1α <sup><xref ref-type="bibr" rid="R2">2</xref></sup>. I206 is conserved in SACK1F and SACK1G, while other members have a similar hydrophobic leucine residue at this position.</p></sec></sec><sec id="S19" sec-type="discussion"><title>Discussion</title><p id="P21">Based on high-throughput fragment screening data, we previously reported a method to define ligand-binding clusters on proteins to ascertain impact on protein function. In this manuscript we focused on one protein, namely SACK1B, and identified a ligand-binding pocket within its SACK1 domain as potentially functionally significant. There are some reports suggesting the role of SACK1B in promoting cancer cell proliferation and mediating resistance to TKI inhibitors <sup><xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R65">65</xref></sup>, however its precise molecular role remains elusive. Because of this, we modelled the structure of the conserved SACK1 domain of the better characterised SACK1G. We classified residues near the ligand-binding site into high, medium and low likelihood of functional impact based on conservation and missense depletion scores. We then mutated two residues from each category from SACK1G to test their effect on CK1α binding. Excitingly, two mutations, namely I206A (high likelihood) and Y204A (medium likelihood), completely abolished the binding to CK1α in cells. Consistent with this loss of interaction with CK1α, degraders of CK1α that also co-degrade native SACK1G failed to degrade I206A and Y204A mutants. Loss of CK1α binding and subsequent inhibition of WNT signalling underlies the pathogenesis of PPK caused by <italic>SACK1G</italic> mutations within the SACK1 domain <sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup>. It would be interesting to investigate whether I206 and Y204 mutations are also associated with PPK or if loss of SACK1G-CK1α interaction by I206A and Y204A mutations also lead to inhibition of WNT signalling <sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup>. Within the vicinity of this predicted ligand-binding pocket on SACK1G are conserved residues D262 and F296, which have previously been shown to play critical role in CK1α binding and activation of WNT signalling <sup><xref ref-type="bibr" rid="R4">4</xref></sup>. Therefore, developing the current low-affinity small fragments into selective ligands within this pocket may yield ligands with potential functional consequence that might prove useful tools for exploring the cellular functions of SACK1G-CK1α complexes. Unlike SACK1G which selectively binds CK1α, SACK1B binds to CK1α, CK1δ and CK1ε <sup><xref ref-type="bibr" rid="R2">2</xref></sup>. Therefore, it would be interesting to test whether the equivalent mutations on FAM83B, namely L179A and Y177A, also abolish interactions with CK1α, CK1δ and CK1ε.</p></sec><sec id="S20" sec-type="conclusions"><title>Conclusions</title><p id="P22">The conclusions resulting from this work are as follows:</p><list list-type="bullet" id="L1"><list-item><p id="P23">Modelling SACK1G as its biologically functional dimer improves the quality of the structure prediction relative to that of a monomeric model.</p></list-item><list-item><p id="P24">A C1 site in SACK1G – as predicted by Utgés <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R35">35</xref></sup> – is experimentally shown to be functional, as mutations within the site abolish binding to its partner CK1α.</p></list-item></list></sec><sec id="S21"><title>Statistics and reproducibility</title><p id="P25">PDB accession codes for the eleven SACK1B/FAM83B fragment screening structures are the following: 5QHI <sup><xref ref-type="bibr" rid="R19">19</xref></sup>, 5QHJ <sup><xref ref-type="bibr" rid="R20">20</xref></sup>, 5QHK <sup><xref ref-type="bibr" rid="R21">21</xref></sup>, 5QHL <sup><xref ref-type="bibr" rid="R22">22</xref></sup>, 5QHM <sup><xref ref-type="bibr" rid="R23">23</xref></sup>, 5QHN <sup><xref ref-type="bibr" rid="R24">24</xref></sup>, 5QHO <sup><xref ref-type="bibr" rid="R25">25</xref></sup>, 5QHP <sup><xref ref-type="bibr" rid="R26">26</xref></sup>, 5QHQ <sup><xref ref-type="bibr" rid="R27">27</xref></sup>, 5QHR <sup><xref ref-type="bibr" rid="R28">28</xref></sup> and 5QHS <sup><xref ref-type="bibr" rid="R29">29</xref></sup>. Colabfold v1.5.2 was utilised for 3D structure prediction. Computational analysis was carried out primarily with the following Python libraries: Matplotlib <sup><xref ref-type="bibr" rid="R66">66</xref></sup>, Pandas <sup><xref ref-type="bibr" rid="R67">67</xref>,<xref ref-type="bibr" rid="R68">68</xref></sup> and SciPy <sup><xref ref-type="bibr" rid="R69">69</xref></sup> and Seaborn <sup><xref ref-type="bibr" rid="R70">70</xref></sup>.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS207040-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d14aAcGbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements</title><p>We thank Dr James Abbot for the Colabfold implementation on the cluster and for advice on how to run predictions. We also thank the IT service of the University of Dundee for their support of the HPC infrastructure this study was carried out on. We thank the members of G.P.S. lab for experimental advice and discussions during the study. We thank the MRC tissue culture facility staff (E. Allen, A. Muir, S. Dalglish, E. Webster and J. Stark), the staff at the DNA Sequencing services (School of Life Sciences, University of Dundee), the cloning, antibody, inhibitor and protein production teams within the MRC PPU Reagents &amp; Services (University of Dundee) coordinated by J. Hastie and the staff at FACS service for their technical and reagents support. We thank Christina Woo (Broad Institute of MIT and Harvard) for providing us with DEG-77.</p><sec id="S23"><title>Funding</title><p>This work was supported by grants to G.J.B. from UKRI-Biotechnology and Biological Sciences [BB/X018628/1] and Wellcome Trust [101651/Z/13/Z; 218259/Z/19/Z] and by grants to G.P.S. [UKRI Medical Research Council: MC_UU_00018/6 and MC_UU_00038/6]. G.P.S. is also supported by Boehringer-Ingelheim (through the Division of Signal Transduction Therapy). J.S.U. was supported by a BBSRC EASTBIO Ph.D. Studentship [BB/J01446X/1]. L.G. and B.L.C. are supported by the MRC PPU PhD studentships.</p></sec></ack><sec id="S24" sec-type="data-availability"><title>Data availability</title><p id="P26">All the 3D structure models and predictions analysed in this work can be found in the following GitHub repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/bartongroup/SACK1G-analysis">https://github.com/bartongroup/SACK1G-analysis</ext-link> <sup><xref ref-type="bibr" rid="R71">71</xref></sup>. The raw data generated for this study is available at Mendeley (link will be added here following revisions).</p></sec><sec id="S25" sec-type="data-availability"><title>Code availability</title><p id="P27">The code developed to carry out this analysis is available from our GitHub repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/bartongroup/SACK1G-analysis">https://github.com/bartongroup/SACK1G-analysis</ext-link>.</p></sec><fn-group><fn fn-type="con" id="FN1"><p id="P28"><bold>Author contributions</bold></p><p id="P29">J.S.U. and G.J.B. conceived, designed and developed the computational side of the work. D.L.Z.X., B.L.C., and L.G. performed biochemical and cell-based experiments, analysed data and compiled figures. J.S.U. developed the code and performed the bioinformatics analysis. T.J.M. and N.T.W. generated constructs used in this study. J.S.U., G.J.B, and G.P.S. wrote, reviewed and edited the manuscript. G.P.S. and G.J.B. secured funding and supervised the project.</p></fn><fn fn-type="conflict" id="FN2"><p id="P30"><bold>Competing interests</bold></p><p id="P31">The Sapkota laboratory receives or has received sponsored research support from Amgen, Boehringer Ingelheim, GlaxoSmithKline and Johnson &amp; Johnson. The authors declare no other competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozatzi</surname><given-names>P</given-names></name><name><surname>Sapkota</surname><given-names>GP</given-names></name></person-group><article-title>The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms</article-title><source>Biochem Soc Trans</source><year>2018</year><volume>46</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1042/BST20160277</pub-id><pub-id pub-id-type="pmcid">PMC6008594</pub-id><pub-id pub-id-type="pmid">29871876</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulcher</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms</article-title><source>Sci Signal</source><year>2018</year><volume>11</volume><pub-id pub-id-type="doi">10.1126/scisignal.aao2341</pub-id><pub-id pub-id-type="pmcid">PMC6025793</pub-id><pub-id pub-id-type="pmid">29789297</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulcher</surname><given-names>LJ</given-names></name><name><surname>Sapkota</surname><given-names>GP</given-names></name></person-group><article-title>Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity</article-title><source>Biochem J</source><year>2020</year><volume>477</volume><fpage>4603</fpage><lpage>4621</lpage><pub-id pub-id-type="doi">10.1042/BCJ20200506</pub-id><pub-id pub-id-type="pmcid">PMC7733671</pub-id><pub-id pub-id-type="pmid">33306089</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozatzi</surname><given-names>P</given-names></name><etal/></person-group><article-title>PAWS1 controls Wnt signalling through association with casein kinase 1alpha</article-title><source>EMBO Rep</source><year>2018</year><volume>19</volume><pub-id pub-id-type="doi">10.15252/embr.201744807</pub-id><pub-id pub-id-type="pmcid">PMC5891436</pub-id><pub-id pub-id-type="pmid">29514862</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>KZL</given-names></name><etal/></person-group><article-title>Pathogenic FAM83G palmoplantar keratoderma mutations inhibit the PAWS1:CK1alpha association and attenuate Wnt signalling</article-title><source>Wellcome Open Res</source><year>2019</year><volume>4</volume><fpage>133</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15403.2</pub-id><pub-id pub-id-type="pmcid">PMC6798324</pub-id><pub-id pub-id-type="pmid">31656861</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachie-Menson</surname><given-names>T</given-names></name><etal/></person-group><article-title>Characterisation of the biochemical and cellular roles of native and pathogenic amelogenesis imperfecta mutants of FAM83H</article-title><source>Cell Signal</source><year>2020</year><volume>72</volume><elocation-id>109632</elocation-id><pub-id pub-id-type="doi">10.1016/j.cellsig.2020.109632</pub-id><pub-id pub-id-type="pmcid">PMC7284315</pub-id><pub-id pub-id-type="pmid">32289446</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>K</given-names></name><name><surname>Macartney</surname><given-names>TJ</given-names></name><name><surname>Sapkota</surname><given-names>GP</given-names></name></person-group><article-title>IMiDs induce FAM83F degradation via an interaction with CK1alpha to attenuate Wnt signalling</article-title><source>Life Sci Alliance</source><year>2021</year><volume>4</volume><pub-id pub-id-type="doi">10.26508/lsa.202000804</pub-id><pub-id pub-id-type="pmcid">PMC7768194</pub-id><pub-id pub-id-type="pmid">33361334</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>K</given-names></name><etal/></person-group><article-title>FAM83F regulates canonical Wnt signalling through an interaction with CK1alpha</article-title><source>Life Sci Alliance</source><year>2021</year><volume>4</volume><pub-id pub-id-type="doi">10.26508/lsa.202000805</pub-id><pub-id pub-id-type="pmcid">PMC7768192</pub-id><pub-id pub-id-type="pmid">33361109</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glennie</surname><given-names>L</given-names></name><etal/></person-group><article-title>A novel FAM83G variant from palmoplantar keratoderma patient disrupts WNT signalling via loss of FAM83G-CK1alpha interaction</article-title><source>Open Biol</source><year>2024</year><volume>14</volume><elocation-id>240075</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.240075</pub-id><pub-id pub-id-type="pmcid">PMC11265864</pub-id><pub-id pub-id-type="pmid">39043225</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulcher</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>FAM83D directs protein kinase CK1alpha to the mitotic spindle for proper spindle positioning</article-title><source>EMBO Rep</source><year>2019</year><volume>20</volume><elocation-id>e47495</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201847495</pub-id><pub-id pub-id-type="pmcid">PMC6726907</pub-id><pub-id pub-id-type="pmid">31338967</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruthappu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Recessive Mutation in FAM83G Associated with Palmoplantar Keratoderma and Exuberant Scalp Hair</article-title><source>J Invest Dermatol</source><year>2018</year><volume>138</volume><fpage>984</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2017.10.031</pub-id><pub-id pub-id-type="pmcid">PMC5869049</pub-id><pub-id pub-id-type="pmid">29138053</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gisbergen</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Expanding phenotypic insights of palmoplantar keratodermas based on novel FAM83G variants</article-title><source>Br J Dermatol</source><year>2025</year><volume>192</volume><fpage>544</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">39449644</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drögemüller</surname><given-names>M</given-names></name><etal/></person-group><article-title>A mutation in the FAM83G gene in dogs with hereditary footpad hyperkeratosis (HFH</article-title><source>PLoS Genet</source><year>2014</year><volume>10</volume><elocation-id>e1004370</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004370</pub-id><pub-id pub-id-type="pmcid">PMC4022470</pub-id><pub-id pub-id-type="pmid">24832243</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radden</surname><given-names>LA</given-names></name><etal/></person-group><article-title>The wooly mutation (wly) on mouse chromosome 11 is associated with a genetic defect in Fam83g</article-title><source>BMC Res Notes</source><year>2013</year><volume>6</volume><fpage>189</fpage><pub-id pub-id-type="doi">10.1186/1756-0500-6-189</pub-id><pub-id pub-id-type="pmcid">PMC3663780</pub-id><pub-id pub-id-type="pmid">23656696</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CH</given-names></name><etal/></person-group><article-title>CK1alpha ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>E8035</fpage><lpage>E8044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1702763114</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><source>Crystal structure of human BJ-TSA-9</source><year>2014</year><pub-id pub-id-type="doi">10.2210/pdb4urj/pdb</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Structure of the domain of unknown function DUF1669 from human FAM83B</article-title><year>2016</year><pub-id pub-id-type="doi">10.2210/pdb5lzk/pdb</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowling</surname><given-names>FZ</given-names></name><etal/></person-group><article-title>Crystal structure of human PLD1 provides insight into activation by PI(4,5)P(2) and RhoA</article-title><source>Nat Chem Biol</source><year>2020</year><volume>16</volume><fpage>400</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0499-8</pub-id><pub-id pub-id-type="pmcid">PMC7117805</pub-id><pub-id pub-id-type="pmid">32198492</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000271a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhi/pdb</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000709a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhj/pdb</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000010a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhk/pdb</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000551a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhl/pdb</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with OX-145</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhm/pdb</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000622a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhn/pdb</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000010a (II)</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qho/pdb</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000554a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhp/pdb</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000574a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhq/pdb</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FMOPL000635a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhr/pdb</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkas</surname><given-names>DM</given-names></name><etal/></person-group><article-title>PanDDA analysis group deposition of models with modelled events (e.g. bound ligands)</article-title><source>Crystal Structure of human FAM83B in complex with FF000014a</source><year>2018</year><pub-id pub-id-type="doi">10.2210/pdb5qhs/pdb</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>E</given-names></name><etal/></person-group><article-title>Protein complex prediction with AlphaFold-Multimer</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2021.2010.2004.463034</elocation-id><pub-id pub-id-type="doi">10.1101/2021.10.04.463034</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title><source>Nature</source><year>2024</year><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmcid">PMC11168924</pub-id><pub-id pub-id-type="pmid">38718835</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacGowan</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Human Missense Variation is Constrained by Domain Structure and Highlights Functional and Pathogenic Residues</article-title><source>bioRxiv</source><year>2017</year><elocation-id>127050</elocation-id><pub-id pub-id-type="doi">10.1101/127050</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utgés</surname><given-names>JS</given-names></name><name><surname>Tsenkov</surname><given-names>MI</given-names></name><name><surname>Dietrich</surname><given-names>NJM</given-names></name><name><surname>MacGowan</surname><given-names>SA</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Ankyrin repeats in context with human population variation</article-title><source>PLoS Comput Biol</source><year>2021</year><volume>17</volume><elocation-id>e1009335</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009335</pub-id><pub-id pub-id-type="pmcid">PMC8415598</pub-id><pub-id pub-id-type="pmid">34428215</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utgés</surname><given-names>JS</given-names></name><name><surname>MacGowan</surname><given-names>SA</given-names></name><name><surname>Ives</surname><given-names>CM</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Classification of likely functional class for ligand binding sites identified from fragment screening</article-title><source>Commun Biol</source><year>2024</year><volume>7</volume><fpage>320</fpage><pub-id pub-id-type="doi">10.1038/s42003-024-05970-8</pub-id><pub-id pub-id-type="pmcid">PMC10937669</pub-id><pub-id pub-id-type="pmid">38480979</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacGowan</surname><given-names>SA</given-names></name><name><surname>Madeira</surname><given-names>F</given-names></name><name><surname>Britto-Borges</surname><given-names>T</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>A unified analysis of evolutionary and population constraint in protein domains highlights structural features and pathogenic sites</article-title><source>Communications Biology</source><year>2024</year><volume>7</volume><fpage>447</fpage><pub-id pub-id-type="doi">10.1038/s42003-024-06117-5</pub-id><pub-id pub-id-type="pmcid">PMC11009406</pub-id><pub-id pub-id-type="pmid">38605212</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><etal/></person-group><article-title>ColabFold: making protein folding accessible to all</article-title><source>Nat Methods</source><year>2022</year><volume>19</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01488-1</pub-id><pub-id pub-id-type="pmcid">PMC9184281</pub-id><pub-id pub-id-type="pmid">35637307</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G</given-names></name><etal/></person-group><article-title>Easy and accurate protein structure prediction using ColabFold</article-title><source>Nat Protoc</source><year>2024</year><pub-id pub-id-type="pmid">39402428</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuff</surname><given-names>JA</given-names></name><name><surname>Clamp</surname><given-names>ME</given-names></name><name><surname>Siddiqui</surname><given-names>AS</given-names></name><name><surname>Finlay</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>JPred: a consensus secondary structure prediction server</article-title><source>Bioinformatics</source><year>1998</year><volume>14</volume><fpage>892</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">9927721</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuff</surname><given-names>JA</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Evaluation and improvement of multiple sequence methods for protein secondary structure prediction</article-title><source>Proteins</source><year>1999</year><volume>34</volume><fpage>508</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">10081963</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>C</given-names></name><name><surname>Barber</surname><given-names>JD</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>The Jpred 3 secondary structure prediction server</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>W197</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn238</pub-id><pub-id pub-id-type="pmcid">PMC2447793</pub-id><pub-id pub-id-type="pmid">18463136</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drozdetskiy</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>C</given-names></name><name><surname>Procter</surname><given-names>J</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>JPred4: a protein secondary structure prediction server</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>W389</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv332</pub-id><pub-id pub-id-type="pmcid">PMC4489285</pub-id><pub-id pub-id-type="pmid">25883141</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><collab>UniProt, C</collab><article-title>UniProt: the Universal Protein Knowledgebase in 2025</article-title><source>Nucleic Acids Res</source><year>2025</year><volume>53</volume><fpage>D609</fpage><lpage>D617</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae1010</pub-id><pub-id pub-id-type="pmcid">PMC11701636</pub-id><pub-id pub-id-type="pmid">39552041</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mistry</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pfam: The protein families database in 2021</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>D412</fpage><lpage>D419</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id><pub-id pub-id-type="pmcid">PMC7779014</pub-id><pub-id pub-id-type="pmid">33125078</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>M</given-names></name><etal/></person-group><article-title>InterPro: the protein sequence classification resource in 2025</article-title><source>Nucleic Acids Res</source><year>2025</year><volume>53</volume><fpage>D444</fpage><lpage>D456</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae1082</pub-id><pub-id pub-id-type="pmcid">PMC11701551</pub-id><pub-id pub-id-type="pmid">39565202</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>TD</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: Meeting modern challenges in visualization and analysis</article-title><source>Protein Sci</source><year>2018</year><volume>27</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1002/pro.3235</pub-id><pub-id pub-id-type="pmcid">PMC5734306</pub-id><pub-id pub-id-type="pmid">28710774</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: Structure visualization for researchers, educators, and developers</article-title><source>Protein Sci</source><year>2021</year><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id><pub-id pub-id-type="pmcid">PMC7737788</pub-id><pub-id pub-id-type="pmid">32881101</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>EC</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: Tools for structure building and analysis</article-title><source>Protein Sci</source><year>2023</year><volume>32</volume><elocation-id>e4792</elocation-id><pub-id pub-id-type="doi">10.1002/pro.4792</pub-id><pub-id pub-id-type="pmcid">PMC10588335</pub-id><pub-id pub-id-type="pmid">37774136</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbrack</surname><given-names>RL</given-names></name></person-group><article-title>Rēs ipSAE loquunt: What’s wrong with AlphaFold’s ipTM score and how to fix it</article-title><source>bioRxiv</source><year>2025</year><elocation-id>2025.2002.2010.637595</elocation-id><pub-id pub-id-type="doi">10.1101/2025.02.10.637595</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>DR</given-names></name><etal/></person-group><article-title>PDBe: improved findability of macromolecular structure data in the PDB</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>D335</fpage><lpage>D343</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz990</pub-id><pub-id pub-id-type="pmcid">PMC7145656</pub-id><pub-id pub-id-type="pmid">31691821</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utgés</surname><given-names>JS</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Comparative evaluation of methods for the prediction of protein-ligand binding sites</article-title><source>J Cheminform</source><year>2024</year><volume>16</volume><fpage>126</fpage><pub-id pub-id-type="doi">10.1186/s13321-024-00923-z</pub-id><pub-id pub-id-type="pmcid">PMC11552181</pub-id><pub-id pub-id-type="pmid">39529176</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utgés</surname><given-names>JS</given-names></name><name><surname>MacGowan</surname><given-names>SA</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>LIGYSIS-web: a resource for the analysis of protein-ligand binding sites</article-title><source>Nucleic Acids Research</source><year>2025</year><elocation-id>gkaf411</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkaf411</pub-id><pub-id pub-id-type="pmcid">PMC12230740</pub-id><pub-id pub-id-type="pmid">40377089</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>SR</given-names></name></person-group><article-title>Multiple alignment using hidden Markov models</article-title><source>Proc Int Conf Intell Syst Mol Biol</source><year>1995</year><volume>3</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">7584426</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenkin</surname><given-names>PS</given-names></name><name><surname>Erman</surname><given-names>B</given-names></name><name><surname>Mastrandrea</surname><given-names>LD</given-names></name></person-group><article-title>Information-theoretical entropy as a measure of sequence variability</article-title><source>Proteins</source><year>1991</year><volume>11</volume><fpage>297</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">1758884</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacGowan</surname><given-names>SA</given-names></name><etal/></person-group><article-title>The Dundee Resource for Sequence Analysis and Structure Prediction</article-title><source>Protein Sci</source><year>2020</year><volume>29</volume><fpage>277</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1002/pro.3783</pub-id><pub-id pub-id-type="pmcid">PMC6933851</pub-id><pub-id pub-id-type="pmid">31710725</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><year>2020</year><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmcid">PMC7334197</pub-id><pub-id pub-id-type="pmid">32461654</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Targeted dephosphorylation of SMAD3 as an approach to impede TGF-beta signaling</article-title><source>iScience</source><year>2024</year><volume>27</volume><elocation-id>110423</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2024.110423</pub-id><pub-id pub-id-type="pmcid">PMC11298613</pub-id><pub-id pub-id-type="pmid">39104417</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Targeted dephosphorylation of TFEB promotes its nuclear translocation</article-title><source>iScience</source><year>2024</year><volume>27</volume><elocation-id>110432</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2024.110432</pub-id><pub-id pub-id-type="pmcid">PMC11284556</pub-id><pub-id pub-id-type="pmid">39081292</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mapping the substrate landscape of protein phosphatase 2A catalytic subunit PPP2CA</article-title><source>iScience</source><year>2024</year><volume>27</volume><elocation-id>109302</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2024.109302</pub-id><pub-id pub-id-type="pmcid">PMC10915630</pub-id><pub-id pub-id-type="pmid">38450154</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piovesan</surname><given-names>D</given-names></name><etal/></person-group><article-title>MOBIDB in 2025: integrating ensemble properties and function annotations for intrinsically disordered proteins</article-title><source>Nucleic Acids Res</source><year>2025</year><volume>53</volume><fpage>D495</fpage><lpage>D503</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae969</pub-id><pub-id pub-id-type="pmcid">PMC11701742</pub-id><pub-id pub-id-type="pmid">39470701</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Dual IKZF2 and CK1alpha degrader targets acute myeloid leukemia cells</article-title><source>Cancer Cell</source><year>2023</year><volume>41</volume><fpage>726</fpage><lpage>739</lpage><elocation-id>e711</elocation-id><pub-id pub-id-type="doi">10.1016/j.ccell.2023.02.010</pub-id><pub-id pub-id-type="pmcid">PMC10466730</pub-id><pub-id pub-id-type="pmid">36898380</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiguchi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Selective CK1alpha degraders exert antiproliferative activity against a broad range of human cancer cell lines</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><elocation-id>482</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-44698-1</pub-id><pub-id pub-id-type="pmcid">PMC10791743</pub-id><pub-id pub-id-type="pmid">38228616</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glennie</surname><given-names>L</given-names></name><etal/></person-group><article-title>The contribution of native protein complexes to targeted protein degradation</article-title><source>bioRxiv</source><year>2025</year><elocation-id>2025.2006.2017.660125</elocation-id><pub-id pub-id-type="doi">10.1101/2025.06.17.660125</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriano</surname><given-names>R</given-names></name><etal/></person-group><article-title>FAM83B mediates EGFR- and RAS-driven oncogenic transformation</article-title><source>J Clin Invest</source><year>2012</year><volume>122</volume><fpage>3197</fpage><lpage>3210</lpage><pub-id pub-id-type="doi">10.1172/JCI60517</pub-id><pub-id pub-id-type="pmcid">PMC3428078</pub-id><pub-id pub-id-type="pmid">22886302</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriano</surname><given-names>R</given-names></name><etal/></person-group><article-title>FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies</article-title><source>Oncotarget</source><year>2013</year><volume>4</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.1027</pub-id><pub-id pub-id-type="pmcid">PMC3742833</pub-id><pub-id pub-id-type="pmid">23676467</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>JD</given-names></name></person-group><article-title>Matplotlib: A 2D Graphics Environment</article-title><source>Computing in Science &amp; Engineering</source><year>2007</year><volume>9</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1109/MCSE.2007.55</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>W</given-names></name></person-group><person-group person-group-type="editor"><name><surname>van der Walt</surname><given-names>Stéfan</given-names></name><name><surname>Millman</surname><given-names>Jarrod</given-names></name></person-group><conf-name>Proceedings of the 9th Python in Science Conference</conf-name><year>2010</year><fpage>56</fpage><lpage>61</lpage></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="book"><collab>pandas-dev/pandas: Pandas v</collab><source>latest</source><publisher-name>Zenodo</publisher-name><year>2020</year></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virtanen</surname><given-names>P</given-names></name><etal/></person-group><article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title><source>Nat Methods</source><year>2020</year><volume>17</volume><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id><pub-id pub-id-type="pmcid">PMC7056644</pub-id><pub-id pub-id-type="pmid">32015543</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waskom</surname><given-names>ML</given-names></name></person-group><article-title>seaborn: statistical data visualization</article-title><source>Journal of Open Source Software</source><year>2021</year><volume>6</volume><fpage>3021</fpage><pub-id pub-id-type="doi">10.21105/joss.03021</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utgés</surname><given-names>JS</given-names></name></person-group><article-title>bartongroup/SACK1G-analysis: Pre-print release (v1.0)</article-title><year>2025</year><pub-id pub-id-type="doi">10.5281/zenodo.15720597</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname><given-names>F</given-names></name><etal/></person-group><article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega</article-title><source>Mol Syst Biol</source><year>2011</year><volume>7</volume><fpage>539</fpage><pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id><pub-id pub-id-type="pmcid">PMC3261699</pub-id><pub-id pub-id-type="pmid">21988835</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Cuff</surname><given-names>J</given-names></name><name><surname>Searle</surname><given-names>SM</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>The Jalview Java alignment editor</article-title><source>Bioinformatics</source><year>2004</year><volume>20</volume><fpage>426</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">14960472</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>AM</given-names></name><name><surname>Procter</surname><given-names>JB</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Jalview Version 2--a multiple sequence alignment editor and analysis workbench</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1189</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id><pub-id pub-id-type="pmcid">PMC2672624</pub-id><pub-id pub-id-type="pmid">19151095</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>SACK1/FAM83B fragment screening sites.</title><p>Twenty-four fragments across eleven PDB structures were grouped into six binding sites with the method of Utgés <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. <bold>(A)</bold> Six defined fragment binding sites for SACK1B/FAM83B on the biologically functional dimer exemplified with PDB: 5QHN <sup><xref ref-type="bibr" rid="R24">24</xref></sup>; <bold>(B)</bold> Missense enrichment score (MES) <italic>vs</italic> normalised Shenkin divergence score (<italic>N<sub>Shenkin</sub></italic>), or <italic>conservation plane</italic>, for the six SACK1B/FAM83B binding sites. Dashed lines indicate conservation (<italic>N<sub>Shenkin</sub></italic> &lt; 50) and missense depletion (MES &lt; 0) thresholds. Sites on the bottom left quadrant are conserved across homologues, depleted in missense variation and more likely to have a role in the protein’s function; <bold>(C)</bold> Binding Site 2 – PDB: 5QHS <sup><xref ref-type="bibr" rid="R29">29</xref></sup>; <bold>(D)</bold> Binding Site 3 – PDB: 5QHL <sup><xref ref-type="bibr" rid="R22">22</xref></sup>; <bold>(E)</bold> Binding Site 0 + Binding Site 5 – PDB: 5QHQ <sup><xref ref-type="bibr" rid="R27">27</xref></sup>. These two sites are very close to each other and were merged into a single site of interest (SI); <bold>(F)</bold> SACK1B/FAM83B site of interest composed of BS0 and BS5 binding residues; <bold>(G)</bold> Conservation plane for the thirteen residues forming the site of interest. Residues were split into three categories by their potential likelihood of function by their conservation and missense depletion scores. Structure visualisation with ChimeraX <sup><xref ref-type="bibr" rid="R47">47</xref></sup>.</p></caption><graphic xlink:href="EMS207040-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>SACK1G/FAM83G SACK1 domain dimer model.</title><p>A Colabfold implementation of AlphaFold Multimer (AFM) was employed to predict the structure of the SACK1G/FAM83G SACK1 domain dimer, from residues 1-315. ipTM = 0.78 and ipSAE = 0.83. <bold>(A)</bold> Model coloured by chain. Residues with pLDDT &gt; 70 are displayed with a surface. Low-confidence regions are displayed with a ribbon; <bold>(B)</bold> Model coloured by pLDDT; <bold>(C)</bold> PAE matrix for the model. There are two defined low PAE regions or <italic>subdomains</italic>. The core of the globular SACK1 domain (128-315 and 443-630) for the first and second SACK1G/FAM83G copy, and a <italic>3-helix region</italic> at 29-73 and 344-388.</p></caption><graphic xlink:href="EMS207040-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>SACK1G/FAM83G dimer model analysis.</title><p><bold>(A)</bold> FAM83G dimer model (residues with pLDDT &gt; 70). ipTM = 0.78 and ipSAE = 0.83. The <italic>3-helix region</italic> located at residues 29-73 is highlighted. There are two previously reported pathogenic variants within this region: SACK1G/FAM83G<sup>A34E 11</sup> and SACK1G/FAM83G<sup>R52P 13</sup>. A34 is predicted to form a network of hydrophobic interactions with five residues. A mutation on this position might disrupt the packing of this region, therefore leading to an abnormal dysfunctional protein product. R52 might play a role in CK1α binding <sup><xref ref-type="bibr" rid="R9">9</xref></sup>; <bold>(B)</bold> Full SACK1G/FAM83G dimer model. High-confidence residues (pLDDT &gt; 70) are represented with surface and low-confidence ones with ribbon. Fragments binding to the SACK1B/FAM83B site of interest fit nicely into the homologous pocket in SACK1G/FAM83G. This site of interest seems to be blocked or covered by a confidently predicted loop located at 129-145, which might act as a regulatory element.</p></caption><graphic xlink:href="EMS207040-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>SACK1G/FAM83G binding site analysis.</title><p>This binding site on SACK1G/FAM83G is defined by the superposition of the SACK1B/FAM83B site of interest to the SACK1G/FAM83G AFM model obtained in this work. <bold>(A)</bold> SACK1G/FAM83G site of interest. Pocket residues are coloured in pink and residues selected for experimental alanine scan, as well as those known to abolish CK1α binding are highlighted; <bold>(B)</bold> Conservation plane for the thirteen residues forming this site in SACK1B/FAM83B. Residues were classified into three groups by their divergence and missense enrichment scores.</p></caption><graphic xlink:href="EMS207040-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>FAM83G/SACK1G I206A and Y204A mutants abolish SACK1G-CK1α binding.</title><p><bold>(A)</bold> The indicated variants of SACK1G derived from <xref ref-type="fig" rid="F4">Figure 4</xref> and Table 1 were stably expressed in SACK1G<sup>-/-</sup> DLD1 cells with a GFP tag at the C-terminus using retroviruses encoding these mutants. Extracts (20 <italic>μ</italic>g protein) were subjected to SDS-PAGE and samples transferred to PVDF membrane, which was subjected to immunoblotting using the indicated antibodies; <bold>(B)</bold> Cleared extracts (1 mg protein) from (A) were subjected to anti-GFP immunoprecipitation (IP) and IPs subjected to SDS-PAGE, transfer to PVDF membrane and immunoblot analysis using the indicated antibodies.</p></caption><graphic xlink:href="EMS207040-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>DEG-77 fails to degrade SACK1G/FAM83G I206A and Y204A mutants</title><p><bold>(A&amp;B)</bold> Wild type DLD1 cells were subjected to treatment with <bold>(A)</bold> the indicated concentrations of DEG-77 for 24 h and <bold>(B)</bold> 100 nM DEG-77 for the indicated times prior to lysis. Extracts (20 <italic>μ</italic>g protein) were subjected to SDS-PAGE and samples transferred to PVDF membrane, which was subjected to immunoblotting using the indicated antibodies; <bold>(C)</bold> Wild type (WT) SACK1G-GFP or the indicated mutants of SACK1G-GFP were stably expressed in SACK1G<sup>-/-</sup> DLD1 cells using retroviruses encoding these mutants. Cells were treated with 100 nM DEG-77 for 24 h prior to lysis. Extracts (20 <italic>μ</italic>g protein) were subjected to SDS-PAGE and samples transferred to PVDF membrane, which was subjected to immunoblotting using the indicated antibodies.</p></caption><graphic xlink:href="EMS207040-f006"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>SACK1G/FAM83G site of interest.</title><p>Thirteen residues forming the site of interest on SACK1G/FAM83G. This ligand binding site of interest is homologous to the one defined from the analysis of the fragment screening experiment of SACK1B/FAM83B. Evolutionary divergence is measured with the normalised Shenkin divergence score (<italic>N<sub>Shenkin</sub></italic>). Enrichment in human missense variation is quantified with the missense enrichment score (MES). Residues were ranked by their conservation and missense scores. The scores are the same as for the SACK1B/FAM83B residues as they are calculated from the multiple sequence alignment column and the residues in both proteins are homologous, i.e., share common ancestry and align in the same column. Group shows the functional likelihood class assigned to each residue based on their ranking. Residues selected for experimental validation are indicated with a check mark (✓).</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="center">Rank</th><th valign="top" align="center">Residue</th><th valign="top" align="center"><italic>N<sub>shenkin</sub></italic></th><th valign="top" align="center">MES</th><th valign="top" align="center">Group</th><th valign="top" align="center">Selected</th></tr></thead><tbody><tr><td valign="top" align="center">1</td><td valign="top" align="center">V175</td><td valign="top" align="center">45</td><td valign="top" align="center">−1.07</td><td valign="top" align="center"><italic><styled-content style="color:#00b050">High</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr><tr><td valign="top" align="center">2</td><td valign="top" align="center">F300</td><td valign="top" align="center">4</td><td valign="top" align="center">−0.55</td><td valign="top" align="center"><italic><styled-content style="color:#00b050">High</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">3</td><td valign="top" align="center">F260</td><td valign="top" align="center">16</td><td valign="top" align="center">−0.41</td><td valign="top" align="center"><italic><styled-content style="color:#00b050">High</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr><tr><td valign="top" align="center">4</td><td valign="top" align="center">I206</td><td valign="top" align="center">13</td><td valign="top" align="center">−0.37</td><td valign="top" align="center"><italic><styled-content style="color:#00b050">High</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr><tr><td valign="top" align="center">5</td><td valign="top" align="center">D262</td><td valign="top" align="center">1</td><td valign="top" align="center">−0.22</td><td valign="top" align="center"><italic><styled-content style="color:#00b050">High</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">6</td><td valign="top" align="center">Y304</td><td valign="top" align="center">18</td><td valign="top" align="center">−0.22</td><td valign="top" align="center"><italic><styled-content style="color:#ffc000">Medium</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">7</td><td valign="top" align="center">Y204</td><td valign="top" align="center">29</td><td valign="top" align="center">−0.22</td><td valign="top" align="center"><italic><styled-content style="color:#ffc000">Medium</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr><tr><td valign="top" align="center">8</td><td valign="top" align="center">D297</td><td valign="top" align="center">40</td><td valign="top" align="center">−0.22</td><td valign="top" align="center"><italic><styled-content style="color:#ffc000">Medium</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">9</td><td valign="top" align="center">G263</td><td valign="top" align="center">25</td><td valign="top" align="center">−0.05</td><td valign="top" align="center"><italic><styled-content style="color:#ffc000">Medium</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">10</td><td valign="top" align="center">A177</td><td valign="top" align="center">43</td><td valign="top" align="center">0.24</td><td valign="top" align="center"><italic><styled-content style="color:#ff0000">Low</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">11</td><td valign="top" align="center">Q301</td><td valign="top" align="center">39</td><td valign="top" align="center">0.33</td><td valign="top" align="center"><italic><styled-content style="color:#ff0000">Low</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr><tr><td valign="top" align="center">12</td><td valign="top" align="center">R233</td><td valign="top" align="center">38</td><td valign="top" align="center">0.67</td><td valign="top" align="center"><italic><styled-content style="color:#ff0000">Low</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✗</bold></td></tr><tr><td valign="top" align="center">13</td><td valign="top" align="center">R235</td><td valign="top" align="center">31</td><td valign="top" align="center">1.04</td><td valign="top" align="center"><italic><styled-content style="color:#ff0000">Low</styled-content></italic> likelihood</td><td valign="top" align="center"><bold>✓</bold></td></tr></tbody></table></table-wrap></floats-group></article>